SCHEMBL5099219

SCHEMBL5099219

CNC1=NCCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11130287 0.85
SCHEMBL7629026 0.78 ADRA2A (0.50)
SCHEMBL3608336 0.74
SCHEMBL3608335 0.74
SCHEMBL19538200 0.74
SCHEMBL24533674 0.73
SCHEMBL10143149 0.73
SCHEMBL19533129 0.73 ADRA2A (0.42)
SCHEMBL12870235 0.73
SCHEMBL4401199 0.72 ADRA2A (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-7062080-A None JP disclosed
CN-118206745-A Compounds and blocking agents comprising the same 菲鹏生物股份有限公司 2024-06-18 CN disclosed
CN-114426494-B Substituted methylamine derivatives acting on TAAR agonist 江苏海洋大学 2023-09-15 CN disclosed
WO-2022271658-A1 TRICYCLIC KRAS INHIBITORS ERASCA, INC. (US) 2022-12-29 WO disclosed
US-20220280527-A1 TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT PURDUE PHARMA L.P. (US) 2022-09-08 US disclosed
CN-114426494-A Substituted methylamine derivative acting on TAAR agonist 江苏海洋大学 2022-05-03 CN disclosed
WO-2021108683-A1 COVALENT RAS INHIBITORS AND USES THEREOF Revolution Medicines, Inc. (US) 2021-06-03 WO disclosed
US-20170313708-A1 NONANOIC AND DECANOIC ACID DERIVATIVES AND USES THEREOF FELIQS CORPORATION (JP) 2017-11-02 US disclosed
US-9790197-B2 Compound, pharmaceutically acceptable salt or optical isomer thereof, method for preparing the same, and pharmaceutical composition for prevention or treatment of viral diseases containing same as active ingredient KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R & D (BE) 2017-10-17 US disclosed
EP-2459542-B1 Substituted N-benzyl-4,5-dihydrooxazol-2-amines useful as selective alpha 2B/2C receptor agonists ALLERGAN INC (US) 2014-10-29 EP disclosed
US-6255493-B1 REACTING IMIDATE ESTER WITH CHIRAL ALCOHOL IN PRESENCE OF TRANSITION METAL CATALYST TO FORM BIS(4-(R)-PHENYLOXAZOLIN-2-YL-METHYL)AMINE LIGANDS; USE TO MAKE RUTHENIUM CATALYST FOR TRANSFER HYDROGENATION THE PENN STATE RESEARCH FOUNDATION 2001-07-03 US disclosed
EP-1030849-A1 TRANSITION METAL-CATALYZED REACTIONS BASED ON CHIRAL AMINE OXAZOLINYL LIGANDS The Pennsylvania State University (US) 2000-08-30 EP disclosed
WO-1999024410-A1 TRANSITION METAL-CATALYZED REACTIONS BASED ON CHIRAL AMINE OXAZOLINYL LIGANDS THE PENN STATE RESEARCH FOUNDATION (US) 1999-05-20 WO disclosed
CN-1186494-A Antibacterial cephalosporins BIOCHEMIE GMBH (AT) 1998-07-01 CN disclosed
EP-0824535-A1 ANTIBACTERIAL CEPHALOSPORINS BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 1998-02-25 EP disclosed
WO-1996035692-A1 ANTIBACTERIAL CEPHALOSPORINS BIOCHEMIE GESELLSCHAFT MBH (AT) 1996-11-14 WO disclosed
JP-H0762080-A PRODUCTION OF POLYCARBONATE RESIN TEIJIN LTD 1995-03-07 JP disclosed
EP-0030350-B1 METHOD FOR REDUCING THE TERMINAL CARBOXYL GROUP CONTENT OF A SATURATED POLYESTER, A SATURATED POLYESTER HAVING A REDUCED TERMINAL CARBOXYL GROUP CONTENT, AND A MOLDED ARTICLE COMPOSED OF SUCH A SATURATED POLYESTER TEIJIN LIMITED (JP) 1984-10-10 EP disclosed
US-4351936-A COMPRISING ENDCAPPING WITH AN OXAZOLINE OR OXAZINE TEIJIN LIMITED (JP) 1982-09-28 US disclosed
EP-0030350-A1 Method for reducing the terminal carboxyl group content of a saturated polyester, a saturated polyester having a reduced terminal carboxyl group content, and a molded article composed of such a saturated polyester TEIJIN LIMITED (JP) 1981-06-17 EP disclosed